The Health Sciences Center at Prisma Health announces a call for Research Seed Grant applications supporting research that improves health. Projects should focus on improvement of health system performance, population health, or biomedical science that translates to clinical practice and improved patient outcomes.
The Research Seed Grant initiative facilitates collaborative pilot research and scholarly activities supporting Prisma Health’s research goals and priorities and those of its university partners (Clemson University, Furman University and University of South Carolina). Seed Grants in the areas of health system performance, population health, and biomedical sciences are supported through funding from Prisma Health and academic partners. Additionally, Prisma Health Cancer Institute will fund Cancer Care Delivery Research (CCDR) Seed Grants. Applicants may request a funding amount up to $20,000. Applicants may cite matching funds from their respective units or from other sources, but cost-share is not required.
No Cost Extension Request
No cost extensions may be available by request only. The request must be received a minimum 30 days prior to the project end date. Requests extend the project end date including budget spend, but do not allocate further funding beyond the originally awarded budget.
Reporting templates will be sent to the PI at the the half-way point of the project period and at the end of the project term.
The 2020-2021 call and application period is now closed. The next call will be distributed in late summer to early Fall 2021.
For specific questions regarding submission forms and process, please contact Rebecca Atkinson.
Key Submission Dates and Deadlines
Letter of Intent (LOI) due Friday, October 23, 2020 at 5:00 pm (EST).
Full Application due December 21, 2020 at 5:00 pm (EST). Selected LOIs will be invited to submit a full application.
Windsor Sherrill, PhD
Chief Science Officer
Desmond Kelly, MD
Chief Medical Research Officer and
Interim Research Director- UofSC-SOMG
Tom Britt, PhD
Clemson HSC Director
Lucia Gonzales, PhD
Associate Director for Clemson Nursing Research
USC HSC Director
Erin Hahn, PhD
Furman HSC Director
Matthew Hudson, PhD
Cancer Care Delivery Research
Past Awarded Seed Grant Projects
2016 Transformative Seed Grant: Awarded Projects
- Cognition in the Bone Marrow Transplant Population (Brooks/Gibson) $15,884
- HRV Biofeedback: A Patient Centered Therapy for Chronic Pain and Other Symptoms of Sickle Cell Disease (Saha/Burch) $20,000
- A Barrier Analysis for Improving Access to 17-alpha hydroxyprogesterone caproate (17-OH-P) for the Prevention of Recurrent Spontaneous Preterm Birth in South Carolina: A Roadmap towards Health Equity (Eichelberger/Lopez de Fede) $20,000
- Assessing the Relevance of Protein Immobilization for the Rational Design of Paper-Based Analytical Devices (Garcia/Edenfield) $20,000
- Reducing Variation of Radiologist Measurement of Lung Cancer and Hepatic Metastasis Lesions Presented in CT Scan Images through a Physician-driven Clinical Decision Support Tool (Lowe/Gimbel) $20,000
- Impact of Music Interventions on Critical Care Patients (Stenbit/Spencer) $14,859
- Patient Decision Aid about Electronic Cigarettes: A Feasibility Study (Thrasher/Albano) $19,960
- Usability Assessment of a Patient-centered Mobile Health Application (iHeartU) for Self-management of Heart Failure (Zhang/Jindal) $20,000
2015 Transformative Seed Grant: Awarded Projects
- A Prospective Randomized Comparative Parallel Study of Amniotic Membrane Wound Graft in the Management of Venous Stasis Ulcers (Oliver, Mercuri) $20,000
- Mindfulness Intervention to Improve Symptomology Among Cancer Survivors: Focus on Sleep and Stress Improvement (O’Rourke, Robb, Wirth, Herbert, Hudson) $19,891
- A Novel Group Prenatal Care Model for Pregnant Women with Diabetes and/or Obesity: A Pilot Study (Schellinger, Zhang, Chen) $19.801
- Immune Reactivation and Apoptosis Induction in Breast Cancer w/Bifusional Fusion Proteins Using Nanotechnology (Wei, Edenfield) $20.000
- Evaluating the Effects of Acupuncture in the Treatment of Taxane Induced Peripheral Neuropathy (TIPN) (LeClair, Franco, O’Rourke) $20,000